DOD Breast Cancer Impact Award

Post Date

February 23rd 2012

Application Due Date

August 15th 2012

Funding Opportunity Number

W81XWH-12-BCRP-IMPT

CFDA Number(s)

12.420

Funding Instrument Type(s)

Cooperative Agreement
Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

5

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $15000000

• Award Range:

  $None - $None

Grant Description

The BCRP Impact Award supports research projects (from small- to large-scale) that specifically focus on scientific and clinical breast cancer issues, which, if successfully addressed, will revolutionize the understanding, prevention, and/or treatment of breast cancer and make major advances toward the goal of ending the disease. The BCRP particularly encourages applications that focus on poorly understood issues that are of critical significance in breast cancer, such as those related to prevention, susceptibility, recurrence, or metastasis. The proposed work must be based on sound overall research and fully supported by preliminary data and/or published reports. Impact: The most important aspect of the Impact Award is the potential of the proposed research to have an unprecedented impact on reducing breast cancer incidence, recurrence, and/or mortality. The research project may be from any discipline or combination of disciplines, including basic, translational, clinical (clinical trials are allowed), behavioral, and/or epidemiological research. The potential impact may be near-term or long-term, but it must be significant and non-incremental. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate the potential impact on breast cancer and to convey its level of significance. Partnering PI Option: The Impact Award mechanism encourages applications that include meaningful and productive collaborations between investigators. The Partnering PI Option under the Impact Award mechanism is structured to accommodate two PIs, who will each receive a separate award. One partner is identified as the Initiating PI and the other partner is identified as the Partnering PI. The Initiating and Partnering PIs have different submission requirements; however, both PIs should contribute to the preparation of a single application. The collaborative partners may have expertise in similar or disparate scientific disciplines, but each partner is expected to bring different strengths to the application. New collaborations are encouraged, but not required. It is the responsibility of the collaborating investigators to describe how their combined expertise in the collaboration will better address the research question and explain why the work should be done together rather than through separate efforts.

Contact Information

• Agency

  Department of Defense

• Office:

  Dept. of the Army -- USAMRAA

• Agency Contact:

  CDMRP Help Desk: 301-682-5507; help@cdmrp.org

• Agency Mailing Address:

  CDMRP Help Desk

• Agency Email Address:

  help@cdmrp.org